Malaysia Over-the-Counter (OTC) Healthcare Market Size by Categories, Distribution Channel, Market Share and Forecast, 2021-2026
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Malaysia over-the-counter (OTC) healthcare market size was valued at $600 million in the year 2021. The market is expected to grow at a CAGR of more than 4% during the forecast period. The Malaysia OTC healthcare market report provides insights on high growth markets to target, trends in the usage of category level distribution data and companies market shares.
Malaysia OTC healthcare market outlook
For more insights on this report, download a free sample
Which are the key categories in the OTC healthcare market in Malaysia?
The key categories in the OTC healthcare market in Malaysia include analgesics, cough and cold preparations, first aid kits, indigestion preparations, medicated skin products, plasters & bandages, topical OTC medicines, traditional medicines, vitamins and minerals, and other OTC healthcare products. Traditional medicines products category led the Malaysian OTC healthcare sector in terms of per capita expenditure in 2021.
Malaysia OTC healthcare market, by key categories
For more category insights, download a free sample
What are the key distribution channels in the OTC healthcare market in Malaysia?
The key distribution channels in the OTC healthcare market in Malaysia are drug stores/pharmacies, hypermarkets & supermarkets, convenience stores, and food & drinks specialists. Drug stores & pharmacies was the leading distribution channel in the Malaysian OTC healthcare sector.
Malaysia OTC healthcare market, by distribution channels
For more distribution channel insights, download a free sample
Which are the key competitors in the OTC healthcare market in Malaysia?
The key competitors in the OTC healthcare market in Malaysia are GlaxoSmithKline, Xepa-Soul Pattinson (Singapore) Pte Ltd, Sanofi-Aventis SA, Johnson & Johnson Services Inc, Darya-Varia, Xepa-Soul Pattinson (Singapore) Pte Ltd, and Sanofi-Aventis SA.
Malaysia OTC healthcare market, by key competitors
To know more about key competitors, download a free sample
Market report overview
Market size 2021 | $600 million |
CAGR | >4% |
Forecast period | 2021-2026 |
Key categories | Analgesics, Cough and Cold Preparations, First Aid Kits, Indigestion Preparations, Medicated Skin Products, Plasters & Bandages, Topical OTC Medicines, Traditional Medicines, Vitamins and Minerals, and Other OTC Healthcare Products |
Key distribution channel | Drug Store & Pharmacies, Hypermarkets & Supermarkets, Convenience Stores, and Food & Drinks Specialists |
Key competitors | GlaxoSmithKline, Xepa-Soul Pattinson (Singapore) Pte Ltd, Sanofi-Aventis SA, Johnson & Johnson Services Inc, Darya-Varia, Xepa-Soul Pattinson (Singapore) Pte Ltd, and Sanofi-Aventis SA |
Scope
- The per capita expenditure of OTC healthcare in Malaysia was lower than the global level but higher than the regional levels in 2021
- The Malaysian OTC healthcare sector is expected to register growth at a CAGR of more than 4% in terms of value during 2021-2026
- Drug stores & pharmacies was the leading distribution channel in the Malaysian OTC healthcare sector, in 2021
Reasons to Buy
- Identify high potential categories and explore further market opportunities based on detailed value and volume analysis
- Existing and new players can analyze key distribution channels to identify and evaluate trends and opportunities
- Gain an understanding of the total competitive landscape based on detailed company share analysis to plan effective market positioning
- Our team of analysts have placed a significant emphasis on changes expected in the market that will provide a clear picture of the opportunities that can be tapped over the next five years, resulting in revenue expansion
- The packaging analysis report helps manufacturers, in identifying the most commonly used packaging materials in the sector
- Analysis on key macro-economic indicators such as real GDP, nominal GDP, consumer price index, household consumption expenditure, population (by age group, gender, rural-urban split, and employed people and unemployment rate. It also includes economic summary of the country along with labor market and demographic trends.
Johnson & Johnson Services Inc
and Darya-Varia Laboratoria Tbk
Xepa-Soul Pattinson (Singapore) Pte Ltd
Sanofi-Aventis SA
Table of Contents
Table
Figures
Frequently asked questions
-
What was the Malaysia OTC healthcare market size in the year 2021?
The Malaysia OTC healthcare market size was valued at $600 million in the year 2021.
-
What is the Malaysia OTC healthcare market growth rate?
The Malaysia OTC healthcare market is expected to grow at a CAGR of more than 4% during the forecast period.
-
Which are the key categories in the Malaysia OTC healthcare market?
Analgesics, cough and cold preparations, first aid kits, indigestion preparations, medicated skin products, plasters & bandages, topical OTC medicines, traditional medicines, vitamins and minerals, and other OTC healthcare products are the key categories in the Malaysian OTC healthcare market.
-
What are the key distribution channels in the Malaysia OTC healthcare market?
Drug stores/pharmacies, hypermarkets & supermarkets, convenience stores, and food & drinks specialists are the key distribution channels in the Malaysian OTC healthcare market.
-
Which are the key competitors in the Malaysia OTC healthcare market?
GlaxoSmithKline, Xepa-Soul Pattinson (Singapore) Pte Ltd, Sanofi-Aventis SA, Johnson & Johnson Services Inc, Darya-Varia, Xepa-Soul Pattinson (Singapore) Pte Ltd, and Sanofi-Aventis SA are the key competitors in the Malaysian OTC healthcare market.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.